Drug companies oppose India’s move to slash prices of 50 drugsBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4978 (Published 01 August 2014) Cite this as: BMJ 2014;349:g4978
- Sanjeet Bagcchi
India’s drug price regulator, the National Pharmaceutical Pricing Authority (NPPA), has announced that the prices of 50 cardiovascular and diabetes medicines will be reduced by 35%.
The authority used a rare provision in the Drugs Price Control Order 2013 to make the price changes. The provision allows the regulator to cut the price of medicines in “extraordinary situations” to protect the public interest.
The NPPA told …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial